Linsidomine, with the CAS number 33876-97-0, is a chemical compound primarily known for its role as a vasodilator and its potential therapeutic applications in cardiovascular medicine. It is classified as a nitrovasodilator, which means it releases nitric oxide (NO) upon metabolism, leading to the relaxation of vascular smooth muscle and subsequent dilation of blood vessels. This mechanism is beneficial in treating conditions such as angina pectoris and hypertension. Linsidomine is typically administered in its hydrochloride salt form and is characterized by its relatively low solubility in water, which can influence its pharmacokinetics and bioavailability. The compound has a moderate molecular weight and exhibits a unique structure that contributes to its biological activity. Additionally, linsidomine's effects can vary based on dosage and individual patient factors, necessitating careful consideration in clinical use. As with many pharmacological agents, potential side effects may include headaches, hypotension, and reflex tachycardia, highlighting the importance of monitoring during treatment.

Linsidomine

33876-97-0: Linsidomine, with the CAS number 33876-97-0, is a chemical compound primarily known for its role as a vasodilator and its potential therapeutic applications in cardiovascular medicine. It is classified as a nitrovasodilator, which means it releases nitric oxide (NO) upon metabolism, leading to the relaxation of vascular smooth muscle and subsequent dilation of blood vessels. This mechanism is beneficial in treating conditions such as angina pectoris and hypertension. Linsidomine is typically administered in its hydrochloride salt form and is characterized by its relatively low solubility in water, which can influence its pharmacokinetics and bioavailability. The compound has a moderate molecular weight and exhibits a unique structure that contributes to its biological activity. Additionally, linsidomine's effects can vary based on dosage and individual patient factors, necessitating careful consideration in clinical use. As with many pharmacological agents, potential side effects may include headaches, hypotension, and reflex tachycardia, highlighting the importance of monitoring during treatment.

<p>Lincydomine relaxes smooth muscles, treats unstable angina, and opens human and guinea pig respiratory tracts.</p>

CAS 33876-97-0

Linsidomine

Linsidomine

Ref: TM-T32770